150 related articles for article (PubMed ID: 19572029)
1. Pleuropulmonary Toxicity of Another Anti-Parkinson's Drug: Cabergoline.
Belmonte Y; de Fàbregues O; Marti M; Domingo C
Open Respir Med J; 2009 Jun; 3():90-3. PubMed ID: 19572029
[TBL] [Abstract][Full Text] [Related]
2. Constrictive pericarditis and pleuropulmonary disease linked to ergot dopamine agonist therapy (cabergoline) for Parkinson's disease.
Ling LH; Ahlskog JE; Munger TM; Limper AH; Oh JK
Mayo Clin Proc; 1999 Apr; 74(4):371-5. PubMed ID: 10221467
[TBL] [Abstract][Full Text] [Related]
3. [Two cases of patients with Parkinson's disease developing valvular heart disease while taking cabergoline].
Sato T; Kikuchi A; Onoue N; Hiramoto T; Oumi M; Onodera J
Rinsho Shinkeigaku; 2008 Jul; 48(7):486-91. PubMed ID: 18717182
[TBL] [Abstract][Full Text] [Related]
4. [Early pleuropulmonary toxicity associated with cabergoline, an antiparkinsonian drug].
Villavicencio C; Ramírez-Sarmiento A; Gayete A; Grau S; Orozco-Levi M
Arch Bronconeumol; 2007 Sep; 43(9):519-22. PubMed ID: 17919420
[TBL] [Abstract][Full Text] [Related]
5. Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline.
Frans E; Dom R; Demedts M
Eur Respir J; 1992 Feb; 5(2):263-5. PubMed ID: 1348483
[TBL] [Abstract][Full Text] [Related]
6. Pleural effusion and thickening due to cabergoline use in a patient with Parkinson's disease.
Guptha SH; Promnitz AD
Eur J Intern Med; 2005 Apr; 16(2):129-131. PubMed ID: 15833682
[TBL] [Abstract][Full Text] [Related]
7. Low dose cabergoline induced interstitial pneumonitis.
Frank W; Moritz R; Becke B; Pauli R
Eur Respir J; 1999 Oct; 14(4):968-70. PubMed ID: 10573251
[TBL] [Abstract][Full Text] [Related]
8. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
[TBL] [Abstract][Full Text] [Related]
9. Cabergoline in Parkinson's disease complicated by motor fluctuations.
Geminiani G; Fetoni V; Genitrini S; Giovannini P; Tamma F; Caraceni T
Mov Disord; 1996 Sep; 11(5):495-500. PubMed ID: 8866490
[TBL] [Abstract][Full Text] [Related]
10. [Pleural and parenchymal lung diseases from asbestos exposure. CT diagnosis].
Polverosi R; Vigo M; Citton O
Radiol Med; 2000 Nov; 100(5):326-31. PubMed ID: 11213409
[TBL] [Abstract][Full Text] [Related]
11. [Pleural effusion and pulmonary hypertension in a patient with Parkinson disease treated with cabergoline].
Haro-Estarriol M; Sabater-Talaverano G; Rodríguez-Jerez F; Obrador-Lagares A; Genís-Batlle D; Sendra-Salillas S
Arch Bronconeumol; 2009 Feb; 45(2):100-2. PubMed ID: 19232272
[TBL] [Abstract][Full Text] [Related]
12. Pleural effusion as an isolated finding in COVID-19 infection.
Hussein M; Haq IU; Hameed M; Thomas M; Elarabi A; Allingawi M; Al-Bozom I
Respir Med Case Rep; 2020; 31():101269. PubMed ID: 33134074
[TBL] [Abstract][Full Text] [Related]
13. Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson's disease.
Townsend M; MacIver DH
Heart; 2004 Aug; 90(8):e47. PubMed ID: 15253989
[TBL] [Abstract][Full Text] [Related]
14. IgG4-related pleural disease in a patient with pulmonary adenocarcinoma under durvalumab treatment: a case report.
Terashima T; Iwami E; Shimada T; Kuroda A; Matsuzaki T; Nakajima T; Sasaki A; Eguchi K
BMC Pulm Med; 2020 Apr; 20(1):104. PubMed ID: 32334571
[TBL] [Abstract][Full Text] [Related]
15. Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease.
Antonini A; Poewe W
Lancet Neurol; 2007 Sep; 6(9):826-9. PubMed ID: 17706566
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of cabergoline, new long-lasting D2 agonist in the treatment of Parkinson's disease.
Rabey JM; Nissipeanu P; Inzelberg R; Korczyn AD
Clin Neuropharmacol; 1994 Jun; 17(3):286-93. PubMed ID: 9316674
[TBL] [Abstract][Full Text] [Related]
17. [Pergolide-induced pleural effusion in a patient with juvenile parkinsonism].
Kuwabara T
Rinsho Shinkeigaku; 2002 Aug; 42(8):757-60. PubMed ID: 12701223
[TBL] [Abstract][Full Text] [Related]
18. Investigating a case of recurrent pleural effusion.
Rodrigues P; Neves M; Ferreira JP; Abreu MA; Almeida F
Case Rep Pulmonol; 2011; 2011():695057. PubMed ID: 22937429
[TBL] [Abstract][Full Text] [Related]
19. Pleural small cell carcinoma with massive pleural effusion: A case report.
Jang JG; Jang MH; Ahn JH
Medicine (Baltimore); 2019 Nov; 98(48):e18251. PubMed ID: 31770288
[TBL] [Abstract][Full Text] [Related]
20. Chocolate-Colored Pseudochylothorax in a Woman with a History of Pleuropulmonary Tuberculosis.
Monnerat LB; Louzada EB; Braga VGS; da Cal MS; Lopes AJ; Mafort TT
Am J Case Rep; 2023 Jun; 24():e939473. PubMed ID: 37317516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
